Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Sleep Med. 2014 Dec 18;16(2):288–297. doi: 10.1016/j.sleep.2014.12.004

Table 2.

Mean ± SD actigraphic estimates of sleep onset time, wake time, and total sleep time during baseline (days 1–6 and 8–11) and the 3 treatment days (days 12, 13, and 14) for each bright light group.

Bright Light Group
2 h (30 min × 4) 1 h (15 min × 4) 0.5 h (30 min × 1)
Baseline:
 Sleep Onset Time 00:16 ± 0:48 00:31 ± 1:03 00:17 ± 1:04
 Wake Time 7:55 + 0:43 8:08 ± 1:01 7:54 + 0:59
 Total Sleep Time (h) 6.9 ± 0.4 7.0 ± 0.37 7.0 ± 0.2
Treatment Day 1:
 Sleep Onset Time 00:10 ± 0:44 23:27 ± 1:05 23:10 ± 1:03*
 Wake Time 6:54 ± 0:45 7:13 ± 1:02 6:54 ± 0:58
 Total Sleep Time (h) 6.1 ± 0.5 7.1 ± 0.4* 7.2 ± 0.4*
Treatment Day 2:
 Sleep Onset Time 22:12 ± 0:45 22:24 ± 1:05 22:13 ± 1:04
 Wake Time 5:58 ± 0:46 6:11 ± 1:03 5:48 ± 0:58
 Total Sleep Time (h) 7.0 ± 0.5 7.1 ± 0.4 7.0 ± 0.5
Treatment Day 3:
 Sleep Onset Time 21:13 ± 0:45 21:29 ± 1:06 21:15 ± 1:04
 Wake Time 4:51 ± 0:47 5:11 ± 1:01 4:57 ± 0:58
 Total Sleep Time (h) 6.8 ± 0.7 7.1 ± 0.5 7.0 ± 0.3
*

p<.05 compared to 2 h group.

4 (time) × 3 (bright light group) repeated measures ANOVA:
  • Sleep Onset Time [time: F(3,141) = 6281.5, p <.001]; [time × group: F(6,141) = 91.0, p <.001]
  • Wake Time [time: (F(3,141) = 2682.6, p < .001]
  • Total Sleep Time [time: F(3,141) = 5.0, p = .002]; [time × group: F(6,141) = 17.7, p <.001]